CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.51%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$7.52B
AUM Growth
+$1.2B
(+19%)
Cap. Flow
+$733M
Cap. Flow
% of AUM
9.75%
Top 10 Holdings %
Top 10 Hldgs %
19.11%
Holding
870
New
79
Increased
318
Reduced
279
Closed
56
Top Buys
| 1 |
Amgen
AMGN
|
$78.9M |
| 2 |
Biogen
BIIB
|
$72.5M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$63.8M |
| 4 |
Merck
MRK
|
$58M |
| 5 |
Gilead Sciences
GILD
|
$33.8M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$26.1M |
| 2 |
iRobot
IRBT
|
$15.5M |
| 3 |
Quest Diagnostics
DGX
|
$15.1M |
| 4 |
Colgate-Palmolive
CL
|
$14.9M |
| 5 |
Philip Morris
PM
|
$12.2M |
Sector Composition
| 1 | Healthcare | 33.27% |
| 2 | Technology | 16.05% |
| 3 | Financials | 11.26% |
| 4 | Consumer Discretionary | 7.98% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNSR
201
DELISTED
Finisar Corp
FNSR
| $9.37M | 0.12% |
492,032
+21,564
| +5% | +$411K |
|
202
Apellis Pharmaceuticals
APLS
$3.55B
| $9.17M | 0.12% |
515,700
+275,700
| +115% | +$4.9M |
|
203
Booking.com
BKNG
$178B
| $9.05M | 0.12% |
4,562
-249
| -5% | -$494K |
|
|
MRTX
204
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.04M | 0.12% |
192,000
+99,300
| +107% | +$4.68M |
|
|
IMGN
205
DELISTED
Immunogen Inc
IMGN
| $9.02M | 0.12% |
952,500
+258,500
| +37% | +$2.45M |
|
206
Fortive
FTV
$16.2B
| $9M | 0.12% |
127,723
-170,235
| -57% | -$12M |
|
207
Charter Communications
CHTR
$35.7B
| $9M | 0.12% |
27,609
+3,986
| +17% | +$1.3M |
|
208
Omnicom Group
OMC
$15.4B
| $8.92M | 0.12% |
131,149
+59,857
| +84% | +$4.07M |
|
|
FCE.A
209
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $8.85M | 0.12% |
+352,600
| New | +$8.85M |
|
|
ARNA
210
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $8.83M | 0.12% |
191,970
+93,470
| +95% | +$4.3M |
|
211
CEVA Inc
CEVA
$543M
| $8.76M | 0.12% |
304,798
+13,652
| +5% | +$392K |
|
212
Ultragenyx Pharmaceutical
RARE
$3.07B
| $8.63M | 0.11% |
113,100
+28,100
| +33% | +$2.15M |
|
213
Coty
COTY
$3.81B
| $8.5M | 0.11% |
676,843
+32,233
| +5% | +$405K |
|
214
NextEra Energy, Inc.
NEE
$146B
| $8.44M | 0.11% |
201,380
-21,780
| -10% | -$913K |
|
215
Hewlett Packard
HPE
$31B
| $8.39M | 0.11% |
514,293
-669,272
| -57% | -$10.9M |
|
|
XYZ
216
Block, Inc.
XYZ
$45.7B
| $8.35M | 0.11% |
84,281
-61,905
| -42% | -$6.13M |
|
217
D.R. Horton
DHI
$54.2B
| $8.34M | 0.11% |
197,782
+23,900
| +14% | +$1.01M |
|
218
Corpay
CPAY
$22.4B
| $8.33M | 0.11% |
36,578
+13,243
| +57% | +$3.02M |
|
219
Theravance Biopharma
TBPH
$703M
| $8.32M | 0.11% |
+254,700
| New | +$8.32M |
|
220
BorgWarner
BWA
$9.53B
| $8.32M | 0.11% |
220,883
+114,256
| +107% | +$4.3M |
|
221
Marathon Petroleum
MPC
$54.8B
| $8.21M | 0.11% |
102,629
+3,604
| +4% | +$288K |
|
222
American Water Works
AWK
$28B
| $8.12M | 0.11% |
92,275
-29,211
| -24% | -$2.57M |
|
223
Reinsurance Group of America
RGA
$12.8B
| $7.93M | 0.11% |
54,860
-336
| -0.6% | -$48.6K |
|
|
LJPC
224
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $7.9M | 0.11% |
392,300
+47,000
| +14% | +$946K |
|
225
Phillips 66
PSX
$53.2B
| $7.89M | 0.1% |
70,011
-9,401
| -12% | -$1.06M |
|